Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Autor: Strosberg, J, El Haddad, G, Wolin, E, Hendifar, A, Yao, J, Chasen, B, Mittra, E, Kunz, Pl, Kulke, Mh, Jacene, H, Bushnell, D, O'Dorisio, Tm, Baum, Rp, Kulkarni, Hr, Caplin, M, Lebtahi, R, Hobday, T, Delpassand, E, Van Cutsem, E, Benson, A, Srirajaskanthan, R, Pavel, M, Mora, J, Berlin, J, Grande, E, Reed, N, Seregni, E, Öberg, K, Lopera Sierra, M, Santoro, P, Thevenet, T, Erion, Jl, Ruszniewski, P, Kwekkeboom, D, Krenning, E, Ansquer, C, Baudin, E, Courbon, F, Giammarile, F, Taieb, D, Scheidhauer, K, Weber, M, Bodei, L, Brianzoni, E, DELLE FAVE, Gianfranco, Chiara Grana, M, Mariani, G, Rindi, G, Severi, S, Azevedo, I, Sundin, A, Al‐nahhas, A, Freemantle, N, Grossman, A, Manoharan, P, Anthony, L, Benson, Ab, Garbus, S, Kulke, M, Kvols, L, Metz, D, Morse, M, Schipper, M, Yao, J.

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Strosberg, J, El-Haddad, G, Wolin, E, Hendifar, A, Yao, J, Chasen, B, Mittra, E, Kunz, P L, Kulke, M H, Jacene, H, Bushnell, D, O'Dorisio, T M, Baum, R P, Kulkarni, H R, Caplin, M, Lebtahi, R, Hobday, T, Delpassand, E, Van Cutsem, E, Benson, A, Srirajaskanthan, R, Pavel, M, Mora, J, Berlin, J, Grande, E, Reed, N, Seregni, E, Öberg, K, Lopera Sierra, M, Santoro, P, Thevenet, T, Erion, J L, Ruszniewski, P, Kwekkeboom, D, Krenning, E 2017, ' Phase 3 Trial of (177)Lu-Dotatate for Midgut Neuroendocrine Tumors ', New England Journal of Medicine, vol. 376, no. 2, pp. 125-135 . https://doi.org/10.1056/NEJMoa1607427
New England Journal of Medicine, 376(2), 125-135. Massachussetts Medical Society
Recercat. Dipósit de la Recerca de Catalunya
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Background: Patients with advanced midgut neuroendocrine tumors who have had disease progression during first-line somatostatin analogue therapy have limited therapeutic options. This randomized, controlled trial evaluated the efficacy and safety of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d16eb685cdcea5fc492f1baf8bef39c3
https://doi.org/10.1056/nejmoa1607427

The addition of DTPA to [(177)Lu-DOTA(0),Tyr(3)]occtreotate prior to administration reduces rat skeleton uptake of radioactivity

Autor: Breeman, Wout, van der Wansem, K, Bernard, HF, Gameren, A, Erion, JL, Visser, Theo, Krenning, Eric, Jong, Marion

Publikováno v: European Journal of Nuclear Medicine, 30, 312-315. Springer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::74002f63b7920444f752312c83b76df2
https://pure.eur.nl/en/publications/795509a2-5e76-4d1f-90d0-0d37dc94509a

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr4]octreotate

Autor: Kwekkeboom, Dik, Bakker, WH, Kam, BLR, Teunissen, Jaap, Kooy, PPM, de Herder, W.W., Feelders, R.A., van Eijck, Casper, Jong, Marion, Erion, JL, Krenning, Eric

Publikováno v: European Journal of Nuclear Medicine, 30, 417-422. Springer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::82d50e0e1279a8dc566f3cdba587e24f
https://pure.eur.nl/en/publications/73416d58-5209-43d5-939b-a3eaad952393

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.